Coadministration has not been studied. Paliperidone is primarily eliminated renally, with minimal metabolism occurring via CYP2D6 and CYP3A4. Darunavir/cobicistat could potentially increase paliperidone although to a limited extent therefore no a priori dosage adjustment is needed.